can i take bpc 157 orally How to The Truth About Oral vs

Growth-Factor Signaling and Tissue Repair BPC 157 appears to influence growth factors involved in healing, including vascular endothelial growth factor, or VEGF

Patients who should not receive BPC-157 include: those with active or recent malignancies (due to angiogenic concerns), pregnant or breastfeeding women (no reproductive toxicology data in humans), patients on anticoagulation therapy (theoretical bleeding risk from angiogenesis at ulcer sites), and minors (no pediatric data of any kind)

found that both cI and cIV were deficient in the remaining dopaminergic synapses of idiopathic PD (Reeve et al., 2018)

Endocrine, 15 (1), 9195